Finance and Accounting for Bioscience: CPE Accredited Forum for Emerging Biotechs

Memo

The CPE-accredited Finance and Accounting for Bioscience conference gathers CFOs, Chief Accountants, Controllers, and senior-level finance and accounting leaders representing the spectrum of life sciences organizations in various stages of product lifecycles, from innovative clinical and pre-clinical biotechs through mature commercial-stage bio/pharmaceutical companies, for two days of learning, networking, and strategic collaboration. The event's dual-track format allows attendees to select content aligned with their organization's stage: the Pre-Commercial Track focusing on clinical trial finance and commercialization preparation, or the Commercial Track addressing revenue management, pricing, contracting, and strategic managed markets finance. Featured Sessions:- SEC and FASB Town Hall- CFO Panel: Redefining Financial Leadership for Organizational Success- Closed-Door Executive Think Tank [Industry-Only]- Navigating Clinical Trials Finance: Accruals, Automation, and AI Integration- Controllership Panel: Driving Operational Excellence in a Transforming Landscape- Biotech Financing Insights: Navigating Dynamic Capital Markets- Optimizing ERP Systems: Tools and Strategies for Biotech Growth With CPE credits available and 12 months of post-event access to session recordings, this forum provides both immediate learning and long-term professional development value. Early bird rates and group discounts are available! View the complete agenda and secure your place at https://informaconnect.com/finance-bioscience-east/ Booking: https://go.evvnt.com/3690205-2?pid=5569 Date and Time: On Thu, 24 Sep 2026 07:00 - Fri, 25 Sep 2026 16:00 Venue Details: Sheraton Boston Hotel, 39 Dalton Street, Boston, Massachusetts, 02199, United States Category: Conferences | Science, Health and Medicine | Pharmaceuticals